Skip to main content Skip to navigation


Research Highlights

Researching ALS

Travis Denton, PhD., is currently researching ALS and possible treatments for the disease. He’s been featured in local media and is one of the Gleason Institute’s inaugural fellows.

Denton has received grants from the National Institutes of Neurological Disorders and Stroke to research possible cures for neurodegenerative disease. Denton is an assistant professor in the College of Pharmacy and Pharmaceutical Sciences.

Studying sleep’s impact on Alzheimer’s

The Sleep and Performance Research Center on the WSU Health Sciences Spokane campus offers resources for research work in other areas of WSU. That’s where Jason Gerstner, PhD., went to work on discovering how sleep affects our health, including brain health.

Gerstner of the Elson S. Floyd College of Medicine, focuses his research on sleep and Alzheimer’s, looking at sleep disturbance and possibly delaying the progression of the disease.

Researching possible treatments

New drugs are researched and developed for all sorts of diseases, and Dr. Greg Carter, a clinical faculty member in the Elson S. Floyd College of Medicine, has been involved in clinical trials for a possible treatment for ALS.

Conducting clinical trials is important to understand how these newly developed drugs work and whether there is any future for widespread use.

Research Fellows

Naomi Chaytor
Naomi Chaytor, Ph.D.
Associate Professor, Elson S. Floyd College of Medicine

Area of Interest: New technologies that enable neurocognitive assessment in patients with ALS and related diseases

Travis Denton
Travis Denton, Ph.D.
Assistant Professor, College of Pharmacy and Pharmaceutical Sciences

Area of Interest: New drugs that target neurodegenerative disease

Jason Gerstner
Jason Gerstner, Ph.D.
Assistant Professor, Elson S. Floyd College of Medicine

Area of Interest: New animal models of ALS and related diseases

Donate button